Related Experiment Video
Updated: Aug 18, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Cardiovascular effects of theophylline. Partial attenuation by beta-blockade
Abstract:
The effects of theophylline upon cardiovascular function were studied in 8 male subjects, aged 22-33 years, before and during concomitant administration of metoprolol (50 mg every 6 h) and propranolol (40 mg every 6 h). Theophylline, as aminophylline (6.7-7.3 mg/kg) was given over 30 min. The theophylline level five minutes after completion of the aminophylline infusion was 15.9 +/- 1.8 micrograms/ml in the absence of beta blockade, 16.1 +/- 1.7 micrograms/ml during metoprolol, and 15.1 +/- 1.6 micrograms/ml during propranolol. Theophylline produced a 7% increase in mean arterial pressure which was not attenuated by either metoprolol or propranolol. Heart rate was not changed by theophylline. The QS2 Index (QS2I), a sensitive indicator of inotropism, was shortened from 488 +/- 16 to 476 +/- 16 msec (p less than 0.01) by theophylline alone. After administration of metoprolol or propranolol, theophylline produced no shortening of the QS2I. Theophylline has a mild inotropic effect in healthy subjects. This effect is prevented by pretreatment with beta-adrenergic antagonists.
More Related Videos
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Types of β-Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: β-Blockers
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...

